ERBB2 and breast carcinoma: In breast cancer, the expression of estrogen receptor ER, progesterone receptor PR and human epidermal growth factor receptor HER-2 promotes the occurrence and development of breast cancer through DTX3L-ISG15 signaling pathway 32, 33.